Hiroki Ito

Part of JSR Corp., BION Enterprises Ltd. is a company that manufactures Vitro diagnostic products. The company is based in Des Plaines, IL. Kimimasa Yamada has been the CEO of the company since 2012. BION Enterprises was acquired by MBL International Corp., part of JSR Corp. from July 31, 2019 on July 09, 2008.

MBL International Corp. supplies scientific and diagnostic research products. It offers antibodies, kits and assays, proteins, tetramers and monomers, cell culture, and miscellaneous. Its products are used in academic research institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories. The company was founded in 1993 and is headquartered in Woburn, MA.

ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan.

ReqMed Venture Capital (RMVC) is the investment arm and a wholly-owned subsidiary of ReqMed Co. Ltd. ReqMed is an independent business consulting firm specializing in healthcare, established in 1998 by Kyowa Hakko Kogyo (TSE: 4151), a manufacturer of pharmaceuticals, chemicals and food products. ReqMed is headquartered in Tokyo with an office in San Francisco. The group provides services to innovative drug development businesses. ReqMed stands for Required Medicine. RMVC was established in 2003 and is located in Tokyo. The firm manages specialist venture capital funds. LSVF-I, their first Life Science Venture Fund, was established in 2000. They have entered strategic alliances with Japanese contract-research organizations including CMIC and Fuji Biomedix.

Glycoscience Laboratories, Inc. operates as a holding company that engages in the research and development of medical technologies. The firm also develops glycomedicines, with a focus on finding medical applications for glycosaminoglycans. It provides medical research on proteins, nucleic acids, and carbohydrates. The firm’s business activities include drug discovery, basic cosmetics development, and health food and supplements production. The company was founded by Akira Asari on April 15, 2005 and is headquartered in Tokyo, Japan.

Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan.

JSR Life Sciences Corp. engages in research, development, manufacturing and selling of life science products. The company was founded in February, 2012 and is headquartered in Tsukuba, Japan.